In conclusion, using ILL or mutPAP42mer antigen, PAP-specific T cells were detected in a large proportion of patients with PCa, thereby suggesting it to be a good therapeutic vaccine candidate. The gene discussed is ACP3; the disease is posterior cortical atrophy.